Research Article


Open Access
Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice
Yaser Salaymeh, Marganit Farago, Shulamit Sebban, Batel Shalom, Eli Pikarsky, View ORCID ProfileShulamit Katzav Correspondence email
Yaser Salaymeh
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel
Marganit Farago
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel
Shulamit Sebban
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel
Batel Shalom
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel
Eli Pikarsky
2The Lautenberg Center for Immunology and Cancer Research and Department of Pathology, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel
Shulamit Katzav
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel
Published 10 April 2020. DOI: 10.26508/lsa.202000661

Synergy: Vav1 and KRasG12D in mouse PDAC
Yaser Salaymeh, Marganit Farago, Shulamit Sebban, Batel Shalom, Eli Pikarsky, Shulamit Katzav
Life Science Alliance Apr 2020, 3 (5) e202000661; DOI: 10.26508/lsa.202000661
In this Issue
Volume 3, No. 5
May 2020
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.